This trial studies a new way to manage pain during and after minimally invasive lumbar spine surgery. It looks at using a technique called Erector Spinae Plane Blocks (ESPB) to help reduce the need for opioids after surgery. The goal is to lessen opioid use and its side effects, helping patients recover more comfortably and safely.
This is a Phase 4 trial, meaning it is looking at the effectiveness and safety of the treatment in a real-world setting. The trial is regulated by the FDA and aims to include about 125 participants.
Who can join
Adults aged 18 to 80 can join if they are having specific types of lumbar spine surgery. They should be able to give consent and not be using high doses of opioids before surgery. Some conditions may prevent participation, like certain allergies or diseases. The trial team will confirm who is eligible before participation.
The study team makes the final call on eligibility.
What happens in the study
Participants are randomly assigned to one of two groups. One group receives the ESPB technique with a local anesthetic and clonidine to help with pain. The other group gets a placebo, which is a saline injection that looks the same but has no active medication. Both procedures are done using ultrasound guidance.
Where
This trial is running at 1 location in the United States. It is currently recruiting.